Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model (Q35641792)

9 August 2017

title

Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model (English)

1 reference

9 August 2017

9

Charles G Drake

1 reference

9 August 2017

Tullia C Bruno

1

1 reference

9 August 2017

Cristin Rothwell

2

1 reference

9 August 2017

Joseph F Grosso

3

1 reference

9 August 2017

Derese Getnet

4

1 reference

9 August 2017

Hung Rong Yen

5

1 reference

9 August 2017

Nicholas M Durham

6

1 reference

9 August 2017

George Netto

7

1 reference

9 August 2017

Drew M Pardoll

8

1 reference

9 August 2017

publication date

14 July 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

72

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

514-522

1 reference

Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Myeloid-derived suppressor cells: linking inflammation and cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8+ T lymphocytes into effector CTL.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Clonal deletion of thymocytes as a tumor escape mechanism.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Androgen-independent prostate cancer progression in the TRAMP model

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Maintenance of in vivo tolerance by persistence of antigen

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Studies on the prostate and testis as immunologically privileged sites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

How regulatory T cells work

27 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high-dose self-antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21453

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248615

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

23 October 2018

1 reference

12 December 2020

CD8(+) T cell-mediated spontaneous diabetes in neonatal mice

1 reference

12 December 2020

The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice

1 reference

12 December 2020

Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer

1 reference

12 December 2020

Deletion of idiotype (Id)-specific T cells in multiple myeloma

1 reference

12 December 2020

CD4+ T Cells Pass Through an Effector Phase During the Process of In Vivo Tolerance Induction

1 reference

12 December 2020

Identifiers

DOI

10.1002/PROS.21453

1 reference

9 August 2017

1 reference

9 August 2017

1 reference